University of Texas Southwestern Medical Center: Schizophrenia trials
The registry lists 10 Schizophrenia studies with University of Texas Southwestern Medical Center as lead sponsor. 2 are open to participants now and 4 have results posted.
Phase 1 1Phase 2 1Phase 4 4No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- CLOZAPINE Response in Biotype-1RecruitingNCT04580134Phase 4
- Database Registry for Neural Network Biomarkers in PsychosisRecruitingNCT01409109
- Lurasidone Effects on Tissue Glutamate in SchizophreniaCompletedNCT02199743Phase 4Results posted
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649CompletedNCT00690274Phase 2Results posted
- Demonstrate the Effects of Pramlintide on Weight Reduction in SchizophreniaCompletedNCT00690235Phase 4Results posted
- Treating Cognition in Schizophrenia With Atomoxetine and Cognitive RemediationCompletedNCT00628394Phase 4Results posted
- Aging and Disease Course: Contributions to Lifespan Neurobiology of SchizophreniaActive, not recruitingNCT04951700
- Psychosis and Affective Research Domains and Intermediate PhenotypesCompletedNCT02218853
- Neurophysiological Studies in Schizophrenia and Psychiatric DisordersCompletedNCT01384604
- Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and PharmacokineticsCompletedNCT00628420Phase 1